Randomized open-label crossover assessment of Prograf vs Advagraf on immunosuppressant pharmacokinetics and pharmacodynamics in simultaneous pancreas-kidney patients-Reference-Cited by-同舟云学术

Randomized open-label crossover assessment of Prograf vs Advagraf on immunosuppressant pharmacokinetics and pharmacodynamics in simultaneous pancreas-kidney patients

Published:2018-01-29 Issue:2 Volume:32 Page:e13180
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Cattral Mark¹,Luke Sean²,Knauer Michael J.²^ORCID,Norgate Andrea¹,Schiff Jeffrey¹,Muirhead Norman³,Luke Patrick P.²^ORCID

Affiliation:

1. Department of Surgery; Multi-organ Transplant Program; University of Toronto; Toronto ON Canada

2. Department of Surgery; Multi-organ Transplant Program; Western University; London ON Canada

3. Department of Medicine; Multi-organ Transplant Program; Western University; London ON Canada

Funder

Astellas Pharma

Publisher

Wiley

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ctr.13180/fullpdf

Reference18 articles.

1. Jun H Kim MG Jung CW Clinical advantages including medication adherence with conversion to once-daily advagraf and sirolimus combination in stable kidney recipients 2016 54 81 86

2. Mercuri A Wu S Stranzinger S In vitro and in silico characterisation of tacrolimus released under biorelevant conditions 2016 515 271 280

3. Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs;Dostalek;Clin Pharmacokinet,2012

4. Diabetes mellitus: new challenges and innovative therapies;Sena;EPMA J,2010

5. Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up;Spagnoletti;Transplant Proc,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive update of the metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation;Expert Opinion on Drug Metabolism & Toxicology;2023-07-03

2. Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-08

3. First World Consensus Conference on pancreas transplantation: Part II – recommendations;American Journal of Transplantation;2021-07-29

4. The use of LCP-Tacrolimus (Envarsus XR) in simultaneous pancreas and kidney (SPK) transplant recipients;The American Journal of Surgery;2020-04

5. Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology;Nature Reviews Rheumatology;2020-02-13